Delayed-Action Preparations

"Delayed-Action Preparations" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Dosage forms of a drug that act over a period of time by controlled-release processes or technology.

Descriptor ID	D003692
MeSH Number(s)	D26.255.210 E02.319.300.253
Concept/Terms	Delayed-Action Preparations Delayed-Action Preparations Delayed Action Preparations Delayed-Action Preparation Controlled-Release Preparations Controlled-Release Preparations Controlled Release Preparations Controlled-Release Preparation Controlled-Release Formulations Controlled Release Formulations Controlled-Release Formulation Sustained-Release Preparations Sustained-Release Preparations Sustained-Release Preparation Extended Release Preparations Extended Release Preparation Slow Release Formulation Sustained Release Formulations Sustained Release Formulation Extended Release Formulations Extended Release Formulation Timed-Release Preparations Timed-Release Preparations Timed Release Preparations Timed-Release Preparation Depot Preparations Depot Preparations Depot Preparation Prolonged-Action Preparations Prolonged-Action Preparations Prolonged-Action Preparation

Below are MeSH descriptors whose meaning is more general than "Delayed-Action Preparations".

Chemicals and Drugs [D]
Pharmaceutical Preparations [D26]
Dosage Forms [D26.255]
Delayed-Action Preparations [D26.255.210]
Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Drug Delivery Systems [E02.319.300]
Delayed-Action Preparations [E02.319.300.253]

Below are MeSH descriptors whose meaning is related to "Delayed-Action Preparations".

Below are MeSH descriptors whose meaning is more specific than "Delayed-Action Preparations".

Delayed-Action Preparations
Drug Implants
Tablets, Enteric-Coated

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Delayed-Action Preparations" by people in this website by year, and whether "Delayed-Action Preparations" was a major or minor topic of these publications.

Bar chart showing 67 publications over 21 distinct years, with a maximum of 7 publications in 2005 and 2012

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	0	1	1
2003	0	3	3
2004	0	4	4
2005	0	7	7
2006	0	5	5
2007	0	4	4
2008	0	5	5
2009	0	4	4
2010	1	3	4
2011	0	4	4
2012	4	3	7
2013	0	1	1
2014	0	3	3
2015	0	1	1
2016	0	4	4
2017	1	1	2
2018	1	2	3
2019	1	0	1
2020	0	2	2
2022	0	1	1
2023	0	1	1

Below are the most recent publications written about "Delayed-Action Preparations" by people in Profiles.

Wong MK, Bowers ME, Ventimiglia J, Niknam RM, Moster MR, Pro MJ, Dale E, Kolomeyer NN, Lee D, Zheng CX. Short-Term Outcomes of Bimatoprost Sustained-Release Intracameral Implant in Glaucoma. J Glaucoma. 2023 09 01; 32(9):738-743.

View in: PubMed
DeFrates KG, Engstr?m J, Sarma NA, Umar A, Shin J, Cheng J, Xie W, Pochan D, Omar AK, Messersmith PB. The influence of molecular design on structure-property relationships of a supramolecular polymer prodrug. Proc Natl Acad Sci U S A. 2022 11; 119(44):e2208593119.

View in: PubMed
Klein KO, Freire A, Gryngarten MG, Kletter GB, Benson M, Miller BS, Dajani TS, Eugster EA, Mauras N. Phase 3 Trial of a Small-volume Subcutaneous 6-Month Duration Leuprolide Acetate Treatment for Central Precocious Puberty. J Clin Endocrinol Metab. 2020 10 01; 105(10).

View in: PubMed
Skolnik NS, Nguyen TS, Shrestha A, Ray R, Corbridge TC, Brunton SA. Current evidence for COPD management with dual long-acting muscarinic antagonist/long-acting ?2-agonist bronchodilators. Postgrad Med. 2020 Mar; 132(2):198-205.

View in: PubMed
Campochiaro PA, Marcus DM, Awh CC, Regillo C, Adamis AP, Bantseev V, Chiang Y, Ehrlich JS, Erickson S, Hanley WD, Horvath J, Maass KF, Singh N, Tang F, Barteselli G. The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration: Results from the Randomized Phase 2 Ladder Clinical Trial. Ophthalmology. 2019 08; 126(8):1141-1154.

View in: PubMed
Gupta S, Wang H, Skolnik N, Tong L, Liebert RM, Lee LK, Stella P, Cali A, Preblick R. Treatment Dosing Patterns and Clinical Outcomes for Patients with Type 2 Diabetes Starting or Switching to Treatment with Insulin Glargine (300 Units per Milliliter) in a Real-World Setting: A Retrospective Observational Study. Adv Ther. 2018 01; 35(1):43-55.

View in: PubMed
Aggarwal A, Schrimpf L, Lauriello J. Aripiprazole Long-Acting Injectable for Maintenance Treatment of Bipolar I Disorder in Adults. Clin Schizophr Relat Psychoses. 2018 Jan; 11(4):221-223.

View in: PubMed
Correll CU, Lauriello J. Long-Acting Injectable Antipsychotics: Where Do They Fit in the Treatment Plan? J Clin Psychiatry. 2018 Jan/Feb; 79(1).

View in: PubMed
Foster A, Buckley P, Lauriello J, Looney S, Schooler N. Combination Antipsychotic Therapies: An Analysis From a Longitudinal Pragmatic Trial. J Clin Psychopharmacol. 2017 Oct; 37(5):595-599.

View in: PubMed
Ratay ML, Glowacki AJ, Balmert SC, Acharya AP, Polat J, Andrews LP, Fedorchak MV, Schuman JS, Vignali DAA, Little SR. Treg-recruiting microspheres prevent inflammation in a murine model of dry eye disease. J Control Release. 2017 07 28; 258:208-217.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement